Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

New fully human skin cell culture facilitates grafting

Nov. 6, 2018

Leo Pharma opens phase Ib study of LEO-134310 in chronic plaque psoriasis

Nov. 5, 2018

Clean antagonist antibody can control skin inflammation

Nov. 5, 2018

Boehringer Ingelheim initiates phase I study of BI-730460

Oct. 29, 2018

AQP9 emerges as a candidate gene for keloid development

Oct. 25, 2018

Zymeworks and Leo Pharma enter licensing and research collaboration for bispecific antibodies

Oct. 24, 2018

Hisamitsu begins phase II trial in Japan with HP-5070 for primary local hyperhidrosis

Oct. 24, 2018

New phase II trial explores use of AC-203 for inherited epidermolysis bullosa

Oct. 22, 2018

DS Biopharma presents positive results from Advance phase IIb study of oral DS-107

Oct. 19, 2018

Aslan begins phase I study of ASLAN-004 for atopic dermatitis

Oct. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...